ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
Holders of 5% or more of NDRA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ENDRA Life Sciences Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lipman John C | 13G | 9.99%115.5K shares | New | Oct 30, 20251 filing | Oct 30, 2025 | SEC |
| Digiandomenico Anthony | 13D/A | 9.90%196.7K shares | −0.09 ppfrom 9.99% | Nov 26, 20252 filings | Jun 29, 2026 | SEC |
| ATW Partners Opportunities Management, LLC | 13G | 9.90%116.0K shares | New | Oct 28, 20251 filing | Oct 28, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on ENDRA Life Sciences Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 29, 20269:29 PM ET | Digiandomenico Anthony | 13D/A | 9.90%196.7K shares | −0.09 ppfrom 9.99% | Jun 25, 2026 | SEC |
| Nov 26, 20254:30 PM ET | Digiandomenico Anthony | 13D | 9.99%121.6K shares | New | Oct 15, 2025 | SEC |
| Nov 14, 20254:38 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 3.00%35.6K shares | −3.22 ppfrom 6.22%Below 5% | Nov 14, 2025 | SEC |
| Nov 14, 20258:14 AM ET | S.H.N. Financial Investments Ltd. | 13G/A | 3.00%35.6K shares | –Below 5% | Nov 14, 2025 | SEC |
| Oct 30, 20259:05 AM ET | Lipman John C | 13G | 9.99%115.5K shares | New | Oct 23, 2025 | SEC |
| Oct 28, 20256:43 PM ET | ATW Partners Opportunities Management, LLCand 3 others | 13G | 9.90%116.0K shares | New | Oct 16, 2025 | SEC |
| Feb 14, 20255:04 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 6.22%35.6K shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell ENDRA Life Sciences Inc. shares.
No Form 144 notices for ENDRA Life Sciences Inc. are on file.